Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Vivid Dx

Vivid Dx

Stage unknownUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$15.0Msum of rounds with a disclosed amount only
Named investors
3
Financing history
1 rounds
  1. Jul 28, 2026
    Funding round · $15.0M (disclosed)
    Oxford Science Enterprises (lead)Cedars-Sinai Intellectual Property Co (lead)Jameel Investment Management Company (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Vivid Dx Raises $15M to Help Hospitals Confront One of Modern Medicine's Most Urgent Threats: Drug-Resistant Infections”
Investors on record
3 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Jul 28, 2026
    Vivid Dx announced Funding round of $15,000,000, led by Oxford Science Enterprises, Cedars-Sinai Intellectual Property Co
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company